Search Results Search Sort by RelevanceMost Recent Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Personal Narrative Jun 2019 PrEP and the Judgment of Prevention Samuel Dubin Prevention efforts can marginalize patients by stigmatizing certain behaviors, so distinguishing individual professionals’ preferences about those behaviors is critical. AMA J Ethics. 2019;21(6):E536-539. doi: 10.1001/amajethics.2019.536. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600. Case and Commentary Mar 2016 Ethical Challenges for the Medical Expert Witness Joseph S. Kass, MD, JD and Rachel V. Rose, JD, MBA Medical expert witnesses are ethically and legally obligated to provide honest testimony that meets the standards of the Daubert test. AMA J Ethics. 2016;18(3):201-208. doi: 10.1001/journalofethics.2016.18.3.ecas1-1603. Health Law Apr 2005 Professional Oversight of Expert Testimony Austin v American Association of Neurological Surgeons Alexis Wood Virtual Mentor. 2005;7(4):306-310. doi: 10.1001/virtualmentor.2005.7.4.hlaw1-0504. Case and Commentary Dec 2006 Relief Organizations with Counseling Restrictions Robert D. Orr, MD Virtual Mentor. 2006;8(12):814-817. doi: 10.1001/virtualmentor.2006.8.12.ccas3-0612. Case and Commentary Sep 2006 When Doctors Disagree David J. Casarett, MD, MA Virtual Mentor. 2006;8(9):571-576. doi: 10.1001/virtualmentor.2006.8.9.ccas3-0609. Case and Commentary Sep 2006 Discussing Code Status with Patients and Their Families Lorraine M. Stone, MD, MSPH and James A. Tulsky, MD Virtual Mentor. 2006;8(9):559-563. doi: 10.1001/virtualmentor.2006.8.9.ccas1-0609. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Personal Narrative Jun 2019 PrEP and the Judgment of Prevention Samuel Dubin Prevention efforts can marginalize patients by stigmatizing certain behaviors, so distinguishing individual professionals’ preferences about those behaviors is critical. AMA J Ethics. 2019;21(6):E536-539. doi: 10.1001/amajethics.2019.536.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600.
Case and Commentary Mar 2016 Ethical Challenges for the Medical Expert Witness Joseph S. Kass, MD, JD and Rachel V. Rose, JD, MBA Medical expert witnesses are ethically and legally obligated to provide honest testimony that meets the standards of the Daubert test. AMA J Ethics. 2016;18(3):201-208. doi: 10.1001/journalofethics.2016.18.3.ecas1-1603.
Health Law Apr 2005 Professional Oversight of Expert Testimony Austin v American Association of Neurological Surgeons Alexis Wood Virtual Mentor. 2005;7(4):306-310. doi: 10.1001/virtualmentor.2005.7.4.hlaw1-0504.
Case and Commentary Dec 2006 Relief Organizations with Counseling Restrictions Robert D. Orr, MD Virtual Mentor. 2006;8(12):814-817. doi: 10.1001/virtualmentor.2006.8.12.ccas3-0612.
Case and Commentary Sep 2006 When Doctors Disagree David J. Casarett, MD, MA Virtual Mentor. 2006;8(9):571-576. doi: 10.1001/virtualmentor.2006.8.9.ccas3-0609.
Case and Commentary Sep 2006 Discussing Code Status with Patients and Their Families Lorraine M. Stone, MD, MSPH and James A. Tulsky, MD Virtual Mentor. 2006;8(9):559-563. doi: 10.1001/virtualmentor.2006.8.9.ccas1-0609.